Please use this identifier to cite or link to this item: https://hdl.handle.net/10923/21639
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMAHONEY, KATHLEEN M.-
dc.contributor.authorJACOBUS, SUSANNA-
dc.contributor.authorBHATT, RUPAL S.-
dc.contributor.authorSONG, JIAXI-
dc.contributor.authorCARVO, INGRID-
dc.contributor.authorCHENG, SU-CHUN-
dc.contributor.authorSIMPSON, MEKAILAH-
dc.contributor.authorAndré Poisl Fay-
dc.contributor.authorPUZANOV, IGOR-
dc.contributor.authorMICHAELSON, M. DROR-
dc.contributor.authorATKINS, MICHAEL B.-
dc.contributor.authorMCDERMOTT, DAVID F.-
dc.contributor.authorSIGNORETTI, SABINA-
dc.contributor.authorCHOUEIRI, TONI K.-
dc.date.accessioned2022-05-17T14:47:11Z-
dc.date.available2022-05-17T14:47:11Z-
dc.date.issued2016-
dc.identifier.issn1558-7673-
dc.identifier.urihttps://hdl.handle.net/10923/21639-
dc.language.isoen-
dc.relation.ispartofClinical Genitourinary Cancer-
dc.rightsopenAccess-
dc.titlePhase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma-
dc.typeArticle-
dc.date.updated2022-05-17T14:47:10Z-
dc.identifier.doiDOI:10.1016/j.clgc.2016.02.007-
dc.jtitleClinical Genitourinary Cancer-
dc.volume14-
dc.issue4-
dc.spage304-
dc.epage313.e6-
Appears in Collections:Artigo de Periódico



All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.